What is LOPJLB’s current signal on BCYC?

LOPJLB’s latest quantitative signal on Bicycle Therapeutics plc (BCYC) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is BCYC in?

Bicycle Therapeutics plc (BCYC) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Bicycle Therapeutics plc (BCYC) do?

Bicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. Its core mission is to create innovative therapeutic classes for diseases currently lacking effective treatments. The company's leading investigational product, BT1718, is a Bicycle Toxin Conjugate (BTC) that is undergoing Phase I/IIa clinical trials. This candidate is engineered…